Boardroom Alpha
Meeting calendar
ALTO · Annual meeting · Tuesday, June 23, 2026

Alto Ingredients Inc

5 nominees · 3 ballot items.

Election of five directors; advisory “say-on-pay” vote to approve executive compensation; approval of the 2026 Omnibus Incentive Plan; ratification of RSM US LLP as independent registered public accounting firm.

Market cap
$453M
1Y TSR
+354.5%
Board grade
B+
Record date
Apr 28, 2026
Filing
DEF 14A
Meeting concluded · Jun 23, 2026

Follow how the vote landed and what changed on Alto Ingredients Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect five nominees—Gilbert E. Nathan, Bryon T. McGregor, Dianne S. Nury, Maria G. Gray and Alan R. Tank—to the Board of Directors to serve until the next annual meeting or until successors are elected and qualified.

  2. 2

    Advisory Vote on Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding advisory resolution to approve the compensation paid to named executive officers as disclosed in the proxy statement.

    More detail

    This is a non-binding, advisory 'say-on-pay' proposal asking stockholders to approve the overall compensation of the company’s named executive officers as disclosed in the proxy materials. Management seeks this annual advisory endorsement to confirm alignment between executive pay and company performance and to obtain stockholder feedback; the board recommends a FOR vote, citing the company's pay-for-performance philosophy, the mix of base salary, annual incentives and long-term equity awards, and the Compensation Committee’s processes (including use of performance metrics such as Adjusted EBITDA and KPIs). While advisory and not binding, the Compensation Committee will consider the vote results when setting future compensation. The context includes recent links of pay to performance through performance-based equity awards and an annual cash incentive plan tied to Adjusted EBITDA, KPIs, and individual goals; the company also highlights adjustments made to incentive design following investor feedback. The board recommends approval because it believes the programs attract and retain executives, align management’s interests with stockholders, and appropriately incentivize both short- and long-term value creation.

  3. 3

    Approval of 2026 Omnibus Incentive Plan

    ManagementBoard: FOR

    Approve the Alto Ingredients, Inc. 2026 Omnibus Incentive Plan, authorizing issuance of up to 7,000,000 shares for awards to officers, employees, non-employee directors, consultants and advisors, replacing the 2016 plan.

    More detail

    Management seeks shareholder approval of the 2026 Omnibus Incentive Plan to reestablish a stock-based incentive vehicle following termination of the Prior Plan, authorizing up to 7,000,000 shares (approximately 9% of fully diluted shares as of April 28, 2026). The plan is intended to attract, retain and motivate officers, employees, directors and consultants and to align their interests with stockholders through equity ownership and performance-linked awards. Key governance protections include a 10-year maximum term for options and SARs, prohibition on repricing without shareholder approval, no automatic single-trigger acceleration for change in control (except for non-employee directors), clawback provisions, no dividends on unearned awards, no automatic evergreen share increases, limited share recycling, and minimum vesting requirements with narrowly tailored exceptions. The Compensation Committee will administer the plan and may grant various award types (options, SARs, restricted stock, RSUs, performance awards). Shareholder approval is required under Nasdaq rules for equity plans; failure to approve would leave the company without a stockholder-approved plan for new awards (outstanding Prior Plan awards would remain). The Board recommends FOR because it believes the plan supports competitive compensation, retention, and tax-qualified grant ability while incorporating safeguards to protect shareholders.”},{

Director elections

Nominees on the ballot5

Independent
Tenure on this board
6.7 yrs
Also a director at
Ready Capital Corp (RC)Magnachip Semiconductor Corp (MX)Americas Carmart Inc (CRMT)
Ownership

Top institutional holders10

Latest 13F quarter
1VANGUARD CAPITAL MANAGEMENT LLC4.1%3,180,211$15M
2MARSHALL WACE, LLP3.0%2,361,744$11M
3TWO SIGMA INVESTMENTS, LP2.6%2,006,760$10M
4MILLENNIUM MANAGEMENT LLC2.5%1,915,990$9M
5ARROWSTREET CAPITAL, LIMITED PARTNERSHIP2.3%1,790,263$9M
6RENAISSANCE TECHNOLOGIES LLC2.2%1,673,657$8M
7BlackRock, Inc.1.4%1,110,517$5M
8SUSQUEHANNA INTERNATIONAL GROUP, LLP1.4%1,085,835$5M
9Hillsdale Investment Management Inc.1.3%1,000,703$5M
10Qube Research Technologies Ltd1.3%969,959$5M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Alto Ingredients Inc 2026 annual meeting?
Alto Ingredients Inc (ALTO) holds its 2026 annual shareholder meeting on Tuesday, June 23, 2026.
What is the record date for the Alto Ingredients Inc 2026 meeting?
The record date for the Alto Ingredients Inc 2026 meeting is Tuesday, April 28, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Alto Ingredients Inc's 2026 meeting?
The board is presenting 5 director nominees at the Alto Ingredients Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Alto Ingredients Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Alto Ingredients Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer